Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Show reference:  <a href= "https://www.nejm.org/doi/10.1056/NEJMoa2413449">https://www.nejm.org/doi/10.1056/NEJMoa2413449</a>

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Show reference: https://www.nejm.org/doi/10.1056/NEJMoa2413449

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.&nbsp; Show reference:&nbsp; <a href="https://www.nejm.org/doi/10.1056/NEJMoa2413449" rel="noopener noreferrer">https://www.nejm.org/doi/10.1056/NEJMoa2413449</a>&nbsp;

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Sign up to save your podcasts

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

More shows like Neurology Minute

JAMA Editors' Summary

Neurology® Podcast

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

JAMA Medical News

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio